Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chang, Chih Zen ^a,b,c   Wu, Shu Chuan ^b   Chang, Chia Mao ^b,d   Lin, Chih Lung ^a,b   Kwan, Aij Lie ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARCTIGENIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; FURAN DERIVATIVE; LIGNAN; NITRIC OXIDE; NOS3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCTIUM LAPPA; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; MALE; NONHUMAN; PLEIOTROPY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; ARCTIUM; BIOSYNTHESIS; BRAIN ARTERY; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

ANIMALS; ARCTIUM; CEREBRAL ARTERIES; FURANS; HUMANS; LIGNANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 84946047675     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/490209     Document Type: Article

References (47)

1. J. P. Dreier, S. Major, A. Manning et al., "Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage," Brain, vol. 132, no. 7, pp. 1866-1881, 2009.
2. G. Grasso, "An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage," Brain Research Reviews, vol. 44, no. 1, pp. 49-63, 2004.
3. A. G. Kolias, J. Sen, and A. Belli, "Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches," Journal of Neuroscience Research, vol. 87, no. 1, pp. 1-11, 2009.
4. M.N. Stienen, R. Weisshaupt, J. Fandino et al., "Current practice in neuropsychological outcome reporting after aneurysmal subarachnoid haemorrhage," Acta Neurochirurgica, vol. 155, no. 11, pp. 2045-2051, 2013.
5. C.-H. Chou, S. D. Reed, J. S. Allsbrook, J. L. Steele, K. A. Schulman, and M. J. Alexander, "Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage," Neurosurgery, vol. 67, no. 2, pp. 345-351, 2010.
6. E. S. Connolly, A. A. Rabinstein, J. R. Carhuapoma et al., "Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association," Stroke, vol. 43, no. 6, pp. 1711-1737, 2012.
7. K. P. Budohoski, M. Czosnyka, P. Smielewski et al., "Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study," Stroke, vol. 43, no. 12, pp. 3230-3237, 2012.
8. R. P. Ostrowski, A. R. Colohan, and J. H. Zhang, "Molecular mechanisms of early brain injury after subarachnoid hemorrhage," Neurological Research, vol. 28, no. 4, pp. 399-414, 2006.
9. M. Sabri, A. Kawashima, J. Ai, and R. L. Macdonald, "Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis," Brain Research, vol. 1238, pp. 163-171, 2008.
10. H. Vatter, J. Konczalla, S. Weidauer et al., "Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function," Journal of Neurosurgery, vol. 107, no. 1, pp. 121-127, 2007.
11. S. Ansar, P. Vikman, M. Nielsen, and L. Edvinsson, "Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3750-H3758, 2007.
12. J. Cahill, J.W. Calvert, I. Solaroglu, and J.H. Zhang, "Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage," Stroke, vol. 37, no. 7, pp. 1868-1874, 2006.
13. S. M. D. Mees, A. Algra, W. P. Vandertop et al., "Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial," The Lancet, vol. 380, no. 9836, pp. 44-49, 2012.
14. K. Fabender, B. Hodapp, S. Rossol et al., "Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes," Stroke, vol. 31, no. 12, pp. 2971-2975, 2000.
15. T. Ishrat, I. Sayeed, F. Atif, F. Hua, and D. G. Stein, "Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway," Neuroscience, vol. 210, pp. 442-450, 2012.
16. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A. M. Zeiher, "Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation," Nature, vol. 399, no. 6736, pp. 601-605, 1999.
17. H. Endo, C. Nito, H. Kamada, F. Yu, and P.H. Chan, "Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3β survival signaling," Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 5, pp. 975-982, 2007.
18. E. N. Momin, K. E. Schwab, K. L. Chaichana, R. Miller-Lotan, A. P. Levy, and R. J. Tamargo, "Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage," Neurosurgery, vol. 65, no. 5, pp. 937-945, 2009.
19. M. A. Moro, A. Cárdenas, O. Hurtado, J. C. Leza, and I. Lizasoain, "Role of nitric oxide after brain ischaemia," Cell Calcium, vol. 36, no. 3-4, pp. 265-275, 2004.
20. V. Neuschmelting, S. Marbacher, A.-R. Fathi, S. M. Jakob, and J. Fandino, "Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associatedwith cerebral vasospasm after subarachnoid haemorrhage in rabbits," Acta Neurochirurgica, vol. 151, no. 7, pp. 795-801, 2009.
21. K. Yamashiro, A. B. Milsom, J. Duchene et al., "Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice," Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 8, pp. 1494-1503, 2010.
22. D. M. Arrick and W. G. Mayhan, "Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats," Microcirculation, vol. 17, no. 6, pp. 439-446, 2010.
23. C.-Z. Chang, S.-C. Wu, and A.-L. Kwan, "Magnesium lithospermate B, an active extract of salvia miltiorrhiza, mediates SGC/CGMP/PKG translocation in experimental vasospasm," BioMed Research International, vol. 2014, Article ID 272101, 9 pages, 2014.
24. S. Kästner, M. F. Oertel, W. Scharbrodt, M. Krause, D.-K. Böker, and W. Deinsberger, "Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH," Acta Neurochirurgica, vol. 147, no. 12, pp. 1271-1279, 2005.
25. A. Xie, Y. Aihara, V. A. Bouryi et al., "Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage," Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 10, pp. 1692-1701, 2007.
26. K. Mori, T. Yamamoto, M. Miyazaki et al., "Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model: laboratory investigation," Journal of Neurosurgery, vol. 114, no. 4, pp. 1168-1175, 2011.
27. T. Sasaki, H. Kasuya, H. Onda et al., "Role of p38 mitogenactivated protein kinase on cerebral vasospasm after subarachnoid hemorrhage," Stroke, vol. 35, no. 6, pp. 1466-1470, 2004.
28. P. Vikman, S. Beg, T. Khurana, J. Hansen-Schwartz, and L. Edvinsson, "Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat," Journal of Neurosurgery, vol. 105, no. 3, pp. 438-444, 2006.
29. Z. Wang, G. Chen, W.-W. Zhu, and D. Zhou, "Activation of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the basilar artery after subarachnoid hemorrhage in rats," Annals of Clinical and Laboratory Science, vol. 40, no. 3, pp. 233-239, 2010.
30. C. Zhou, M. Yamaguchi, G. Kusaka, C. Schonholz, A. Nanda, and J. H. Zhang, "Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage," Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 4, pp. 419-431, 2004.
31. M. Herrera, N. J. Hong, P. A. Ortiz, and J. L. Garvin, "Endothelin-1 Lnhibits thick ascending limb transport via Aktstimulated nitric oxide production," The Journal of Biological Chemistry, vol. 284, no. 3, pp. 1454-1460, 2009.
32. K. Kawasaki, R. S. Smith Jr., C.-M. Hsieh, J. Sun, J. Chao, and J. K. Liao, "Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxideinduced endothelial cell migration and angiogenesis," Molecular and Cellular Biology, vol. 23, no. 16, pp. 5726-5737, 2003.
33. S. R. Datta, A. Brunet, and M. E. Greenberg, "Cellular survival: a play in three akts," Genes and Development, vol. 13, no. 22, pp. 2905-2927, 1999.
34. kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway," European Journal of Pharmacology, vol. 747, pp. 71-87, 2015.
35. C. Liu, T. Su, F. Li et al., "PI3K/Akt signaling transduction pathway is involved in rat vascular smoothmuscle cell proliferation induced by apelin-13," Acta Biochimica et Biophysica Sinica, vol. 42, no. 6, pp. 396-402, 2010.
36. X.-Q. Peng, M. Damarla, J. Skirball et al., "Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung," Acta Pharmacologica Sinica, vol. 31, no. 2, pp. 175-183, 2010.
37. F. Roviezzo, S. Cuzzocrea, A. Di Lorenzo et al., "Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock," British Journal of Pharmacology, vol. 151, no. 3, pp. 377-383, 2007.
38. J.-P. Gratton, G. Cournoyer, and P. D'Orléans-Juste, "Endothelin-B receptor-dependent modulation of the pressor and prostacyclin-releasing properties of dynamically converted big endothelin-1 in the anesthetized rabbit," Journal of Cardiovascular Pharmacology, vol. 31, no. 1, pp. S161-S163, 1998.
39. M. K. Cho, J. W. Park, Y. P. Jang, Y. C. Kim, and S. G. Kim, "Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages," International Immunopharmacology, vol. 2, no. 1, pp. 105-116, 2002.
40. Y. P. Jang, S. R. Kim, Y. H. Choi et al., "Arctigenin protects cultured cortical neurons fromglutamate-induced neurodegeneration by binding to kainate receptor," Journal of Neuroscience Research, vol. 68, no. 2, pp. 233-240, 2002.
41. Y. Jeong, J. Park, D. Kim, and H. Kim, "Arctigenin increases hemeoxygenase-1 gene expression by modulating PI3K/AKT signaling pathway in rat primary astrocytes," Biomolecules and Therapeutics, vol. 22, no. 6, pp. 497-502, 2014.
42. H. Liu, Y. Yang, X. Cai, Y. Gao, J. Du, and S. Chen, "The effects of arctigenin on human rheumatoid arthritis fibroblastlike synoviocytes," Pharmaceutical Biology, vol. 5, pp. 1-6, 2015.
43. V. Swarup, J. Ghosh, M. K. Mishra, and A. Basu, "Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan," Journal of Antimicrobial Chemotherapy, vol. 61, no. 3, pp. 679-688, 2008.
44. T. Fan, W. L. Jiang, J. Zhu, and Y. F. Zhang, "Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation," Biological and Pharmaceutical Bulletin, vol. 35, no. 11, pp. 2004-2009, 2012.
45. Z. Zhu, J. Yan, W. Jiang et al., "Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance," Journal of Neuroscience, vol. 33, no. 32, pp. 13138-13149, 2013.
46. F. Raslan, C. Albert-Weißenberger, T. Westermaier, S. Saker, C. Kleinschnitz, and J.-Y. Lee, "Amodified double injection model of cisterna magna for the study of delayed cerebral vasospasm following subarachnoid hemorrhage in rats," Experimental and Translational Stroke Medicine, vol. 4, no. 1, article 23, 2012.
47. B. D. Manning and L. C. Cantley, "AKT/PKB signaling: navigating downstream," Cell, vol. 129, no. 7, pp. 1261-1274, 2007.